June 2010 Issue of MMM
The fine spring weather we've been enjoying here at MM&M has really put us in the mood to break out of the box and explore ...
The formerly sleepy business of marketing devices and diagnostics is getting much savvier amid technological innovations, empowered patients and an ever-more complicated healthcare system, reports ...
SDI's Pharmaceutical Company Image 2010 study is published at the end of June. James Chase previews some of the early findings on the views of ...
Pharmas may be venturing deeper into the online space to build meaningful one-to-one relationships with customers, but direct marketing experts say a multichannel approach still ...
Despite trends compelling firms to ethnically tailor outreach to support brands, multiculturalism is not consistent. Tanya Lewis assesses pharma's cultural IQ and what it takes ...
Mobile's marketing potential stems from its near ubiquity and real power to deliver healthcare value. Will pharma dial up? Marc Iskowitz reports
Products for treating rheumatic and autoimmune diseases--already a $19 billion category--are poised for more growth. Marc Iskowitz finds out why analysts are bullish about the ...
When the Pharmaceutical Marketing Research Group (PMRG) engaged a firm to help craft necessary exclusionary language in the recently passed healthcare reform bill, we ultimately ...
I spend most of my time in this column defending drugs that have been wrongly maligned in the media. Readers know that I am a ...
With many high-margin blockbusters going off patent and a lack of replacements, a Sanford C. Bernstein Research conference explored three potential solutions to the patent ...
Covidien announced the launch of two branded pain drugs--Exalgo and Pennsaid--and hired around 250 reps to support the products.
Impax Pharmaceuticals and Pfizer rejiggered their co-promotion agreement on Pristiq by swapping it out for Lyrica.
Featuring news about Novartis, Avanir Pharmaceuticals and Cutting Edge Information
Med Ed Report
Accredited med ed providers were allowed to try an online system, still in beta phase, for collecting data on their programs and activities last month.
Medical society journals must ban ghostwritten articles and cannot place ads for drugs next to editorial content discussing those products or their makers under a ...
Featuring news about the Society for Academic CME, the National Commission for Certification of CME Professionals, the ACCME and Epocrates
Monthly Prescribing Reference (MPR) covered three new drugs for its inaugural issue, in June 1985. A quarter century and 906 new product editorials later, MPR ...
MDiTV launched an online network featuring daily medical news videos hosted by ex-CNN anchors Andrew Holtz and Cathy Marshall.
Featuring news about Wolters Kluwer Pharma Solutions, inScience Communications, Quadrant HealthCom, Derycz Scientific and Elsevier
A recent survey suggests advertisers want ad networks to provide more insight into where their ads will be placed online before the media buy. Are ...
Bayer Diabetes Care partnered with Nintendo on a glucose meter for kids that incorporates gaming.
Daiichi-Sankyo partnered with the Sjögren's Syndrome Foundation on a survey of 400 patients and launched an unbranded site, LivingWithDryness.com, to raise awareness of the condition.
Featuring news about Lundbeck, MicroMass, Epilepsy.com and My Epilepsy Diary
We in the DTC community are always arguing about the benefit of "unbranded," "disease state" or "information-seeking" advertising.
Sanofi-Aventis US is rolling out a consumer campaign for its Lantus SoloStar pen aimed at getting people with type 2 diabetes to think differently about ...
GlaxoSmithKline is launching a Nicorette lozenge with a snarky new iteration of the "Quitting Sucks" ad campaign and a Facebook contest starring TV shrink Dr. ...
FDA's Division of Drug Marketing, Advertising and Communications (DDMAC) took Novartis to school over educational websites the agency said went beyond disease awareness, and into ...
A survey of patients by HealthCentral found that 30% exhibited characteristics of "empowered patients--problem solvers wanting to understand not only their condition but their treatment ...
Featuring news about DTC advertising, Vaccines for Teens, Sanofi-Pasteur, Society for Adolescent Medicine and Forest Labs
Kantar Health says a new way of leveraging market research helped client Allergan net more from its MR budget while exerting a direct impact on ...
Getting face time with busy physicians is becoming harder for pharma reps every year.
Wunderman named Becky Chidester to head up its global healthcare operations.
The healthcare unit of Omnicom's Diversified Agency Services has contracted with the Center for Communication Compliance for regulatory compliance training and certification.
Featuring news about Compass Healthcare Communications, Compass Healthcare Marketers, GSW Worldwide, LyonHeart and Bayard Advertising Agency
Those who call for FDA to adopt comparative effectiveness as a regulatory third leg are on a cost effectiveness jihad.
Medical product makers should be advised that FDA is planning to aggressively recommend misdemeanor prosecutions against responsible corporate executives for good manufacturing procedures (GMP) violations ...
A commentary in the May American Journal of Public Health calls for adding the "informal and non-advertising forms of drug promotion to a strengthened regulatory ...
Change is here. Not around the corner...it has turned the corner, moved into the fast lane without signaling and dropped it into overdrive.
What a great time we live in as marketers. Today, we can offer our clients more than just the typical sales aid. Now we can ...
Anyone who is involved with the biopharmaceutical industry and who is even half-awake knows how difficult it is for companies to navigate today's increasingly hostile ...
- Five things for pharma marketers to know: Monday, April 24, 2017
- Five things for pharma marketers to know: Friday, April 21, 2017
- Five things for pharma marketers to know: Tuesday, April 25, 2017
- Five things for pharma marketers to know: Wednesday, April 26, 2017
- Drugmakers battle for slice of Humira's billions
- How pharma marketers are using behavioral science
- Veeva and QuintilesIMS tussle over customer reference data
- Genentech urges broader adoption of value-based payment models
- Some brands thought to shift online ad dollars, creating uncertainty for WebMD
- Study: Medical-marijuana laws lower prescription drug usage